Results 131 to 140 of about 40,172 (208)

Circulating Plasmacytoid Dendritic Cells Are Numerically and Functionally Deficient in Trauma Patients. [PDF]

J Innate Immun
Park KJ, Jin HM, Cho YN, Kim JC, Kee SJ, Jo YG, Park YW.   +6 more
europepmc   +1 more source

Spatiotemporal Regulation of Ligand Trafficking and TLR9 Activation by PIEZO1 in Human Plasmacytoid Dendritic Cells. [PDF]

Research (Wash D C)
Pattanayak S, Raychaudhuri D, Bandopadhyay P, Mukhopadhyay U, Mandal T, Liu CSC, Kalidas N, Roychowdhury S, Chattopadhyay K, Ashish F, Sinha B, Ganguly D.   +11 more
europepmc   +1 more source

Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer. [PDF]

J Immunother Cancer
Liu Y, Carter JM, Ma Y, Deshmukh SK, Sledge GW, Balko JM, Kachergus JM, Shi J, Gregory M, Gong J, Joensuu H, Perez EA, Stover D, Carey L, Sikov WM, Leon-Ferre R, Knutson KL, Boughey JC, Ingle JN, Kalari KR, Couch FJ, Asmann YW, Goetz MP, Thompson EA, Chumsri S.   +24 more
europepmc   +1 more source

Reduced Type-I Interferon by Plasmacytoid Dendritic Cells and Asthma in School-Aged Children. [PDF]

Allergy
Coenen I, Jones AC, White AA, Takashima M, Lee WR, Wong MD, Vilcins D, Kadolsky U, Cheema AS, Saxena A, Bosco A, Grimwood K, Sly PD, Strickland DH, Leffler J.   +14 more
europepmc   +1 more source

A Perplexing Predominance of Plasmacytoid Dendritic Cells: Chronic Myelomonocytic Leukemia Initially Considered on a Lymph Node Biopsy. [PDF]

EJHaem
Harris J, Fenu E, Bagg A.
europepmc   +1 more source

Publisher Correction: TNF and type I interferon crosstalk controls the fate and function of plasmacytoid dendritic cells. [PDF]

Nat Immunol
Arroyo Hornero R, Maqueda-Alfaro RA, Solís-Barbosa MA, Leylek RA, Medina Chavez O, Martinez OM, Gottfried-Blackmore A, Idoyaga J.   +7 more
europepmc   +1 more source

The Role of Plasmacytoid Dendritic Cells in the Immune Contexture of <i>TP53</i>-Mutated High-Grade Serous Ovarian Cancer. [PDF]

Cancers (Basel)
Steger K, Fiegl H, Rungger K, Leitner K, Tsibulak I, Feroz B, Ebner C, Marth C, Hackl H, Zeimet AG.   +9 more
europepmc   +1 more source

Targeting Siglec-sialic acid checkpoint to reverse immune dysfunction mediated by plasmacytoid dendritic cells in myeloma. [PDF]

Blood Adv
Ray A, Buon L, Wan X, Du T, Song Y, Pillai SC, Musa MA, Fang T, Wang M, Anderson KC.   +9 more
europepmc   +1 more source

Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections. [PDF]

Nat Immunol
Ngo C, Pierini-Malosse C, Rahmani K, Valente M, Collinet N, Bessou G, Guerry C, Fabregue M, Mathieu S, Sharkaoui S, Mazzoli S, Sansoni A, Fiore F, Laprie C, Alexopoulou L, Gaya M, Gregoire C, Broggi A, Wurbel S, Rua R, Haidar N, Milpied P, Escalière B, Vu Manh TP, Fallet M, Chasson L, Tran H, Baranek T, Le Bert M, Malissen B, Zarubica A, Dalod M, Tomasello E.   +32 more
europepmc   +1 more source

Novel immunotherapy for multiple myeloma involving activation of plasmacytoid dendritic cells. [PDF]

Mol Ther Oncol
Kurimoto M, Watanabe T, Kudo M.
europepmc   +1 more source